Catalog # | CBT-P-021 |
Compound | 7-Deaza-dG (ibu) CE-phosphoramidite |
Chemical Name | 7-[2-Deoxy-5-O-(4,4'-dimethoxytrityl)-ß-D-erythro-pentofuranosyl]-3,7-dihydro-2-[(isobutyryl)amino]-4H-pyrrolo[2,3-d]pyrimidin-4-one 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite |
Formula | C45H55N6O8P |
Molecular Weight | 838.93 g/mol |
Properties | Storage at -18°C Phosphoramidites of 7-deaza-2’-deoxyguanosine (7-deaza-dG) were first prepared in 1985 by Seela and co-workers. Oligonucleotides containing 7-deaza-dG give higher sensitivity in MALDI-TOF spectrometry due to the rather stable glycosidic bond under acidic conditions. The incorporation of this modified nucleoside in place of dG destroys dG-quartets, thereby prohibiting oligonucleotide aggregation during gel electrophoresis or PCR-amplification. Multiple incorporations of 7-deaza-dG might require milder oxidation reagents or the use of our product CBT-P-160. |
Appearance | Off-white foam |
References | F. Seela, H. Driller, Nucleic Acids Res. 1985, 13, 911. F. Seela, H. Driller, Nucleic Acids Res. 1989, 17, 901. |
Quantity | Pricing (EUR) |
50 µmol | |
100 µmol | |
250 mg |